Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial Randomized trials had shown that rituximab maintenance (RM) ...
aDepartment of Hematology, Chongqing Key Laboratory of Hematology and Microenvironment, Army Medical Center, Daping Hospital, Army Medical University of PLA, Chongqing, China ...
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results